Matching Development of Point-of-Care Diagnostic Tests to the Local Context: A Case Study of Visceral Leishmaniasis in Kenya and Uganda

被引:8
作者
Bengtson, Michel [1 ]
Bharadwaj, Mitasha [1 ]
ten Bosch, Astrid [2 ]
Nyakundi, Hellen [3 ]
Matoke-Muhia, Damaris [4 ]
Dekker, Cees [1 ]
Diehl, Jan-Carel [2 ]
机构
[1] Delft Univ Technol, Kavli Inst Nanosci Delft, Dept Bionanosci, Delft, Netherlands
[2] Delft Univ Technol, Fac Ind Design Engn, Dept Sustainable Design Engn, Sect Design Sustainabilily, Delft, Netherlands
[3] Univ Nairobi, Nairobi, Kenya
[4] Kenya Govt Med Res Ctr, Ctr Biotechnol Res & Dev, Nairobi, Kenya
来源
GLOBAL HEALTH-SCIENCE AND PRACTICE | 2020年 / 8卷 / 03期
关键词
MEDICINE;
D O I
10.9745/GHSP-D-20-00028
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The rapid growth of point-of-care (POC) diagnostic tests necessitates a clear vision of when, where, and why a new POC diagnostic test needs to be developed and how it can be used in a way that matches a local health care context. Here, we present an innovative approach toward developing a concept target product profile (CTPP), which is a new mapping tool that helps researchers match a new diagnostic test to a specific local health care context early in the research and development process. As a case study, we focus on the diagnosis of visceral leishmaniasis (VL) in rural resource-limited regions of Kenya and Uganda. Our stepwise approach integrates elements of design thinking and uses a combination of literature reviews and field research for a context analysis of local health care systems and practices. We then use visual thinking in the form of Gigamaps and patient journeys to identify use case scenarios and to present our findings from the field research to key stakeholders. The use case scenarios describe the diagnostic scope of a new POC test based on the feasibility of the new test, the local need, and the contextual fit. For our case study of VL, we identify 2 valuable use case scenarios, namely test-of-cure and screening and confirmation, and we formulate a CTPP. We anticipate that a CTPP will enable researchers to match a new POC diagnostic test during the research and development process to the local health care context in which it will be used.
引用
收藏
页码:549 / 565
页数:17
相关论文
共 40 条
  • [1] Abeijon C, 2019, J CLIN MICROBIOL, V57, DOI [10.1128/JCM.02076-18, 10.1128/jcm.02076-18]
  • [2] Leishmaniasis Worldwide and Global Estimates of Its Incidence
    Alvar, Jorge
    Velez, Ivan D.
    Bern, Caryn
    Herrero, Merce
    Desjeux, Philippe
    Cano, Jorge
    Jannin, Jean
    den Boer, Margriet
    [J]. PLOS ONE, 2012, 7 (05):
  • [3] Aranda-Jan CB, 2016, INT J DES, V10, P43
  • [4] Aronson N, 2016, CLIN INFECT DIS, V63, pE202, DOI [10.1093/cid/ciw670, 10.1093/cid/ciw742]
  • [5] Leishmaniasis
    Burza, Sakib
    Croft, Simon L.
    Boelaert, Marleen
    [J]. LANCET, 2018, 392 (10151) : 951 - 970
  • [6] Diagnostic accuracy of two rK39 antigen-based dipsticks and the formol gel test for rapid diagnosis of visceral leishmaniasis in northeastern Uganda
    Chappuis, F
    Mueller, Y
    Nguimfack, A
    Rwakimari, JB
    Couffignal, S
    Boelaert, M
    Cavailler, P
    Loutan, L
    Piola, P
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (12) : 5973 - 5977
  • [7] CHELALA RMF, 2019, PARASITE EPIDEMIOL C, V7
  • [8] Cruz I, 2019, PARASITE EPIDEMIOL C, V5
  • [9] Diehl Jan Carel, 2015, INT DES C KSDS ADADA
  • [10] Defining the next generation of Plasmodium vivax diagnostic tests for control and elimination: Target product profiles
    Ding, Xavier C.
    Ade, Maria Paz
    Baird, J. Kevin
    Cheng, Qin
    Cunningham, Jane
    Dhorda, Mehul
    Drakeley, Chris
    Felger, Ingrid
    Gamboa, Dionicia
    Harbers, Matthias
    Herrera, Socrates
    Lucchi, Naomi
    Mayor, Alfredo
    Mueller, Ivo
    Sattabongkot, Jetsumon
    Ratsimbason, Arsene
    Richards, Jack
    Tanner, Marcel
    Gonzalez, Iveth J.
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2017, 11 (04):